Collegium Pharmaceutical, Inc. Common Stock

$17.82 -$0.09 -0.51%

Own 1 of COLL at $18.89 which is 0.03% of the portfolio.

-$1.07 (-5.66%)

Shares Bought3
Shares Sold2
Shares Owned1
Last Price$17.82
Total Return-$1.04
Range Today$17.58 - $18.11
52 Week Range$7.37 - $20.92
Market Cap$551.00M
P/E Ratio-

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of next-generation abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. Its products includes Xtampza ER, and ONSOLIS. Xtampza ER provides adequate pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The ONSOLIS is a transmucosal immediate release fetanyl film indicated for the management of breakthrough pain in cancer patients. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Canton, MA.

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners
12-05-17 16:16 $18.89 $17.82 -$1.07 -5.66% michrob topmadhattv

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
08-28-17 18:15 08-31-17 18:14 $10.03 $10.05 +$0.02 +0.21% kurt_woloch
08-28-17 18:10 08-31-17 18:12 $10.04 $10.04 +$0.01 +0.10% grifftenstein